Senseonics (NYSE:SENS) announced that its chief financial officer, Nick Tressler, is transitioning from his position at the CMG company.. Tressler’s transition is effective as of yesterday, Sept. 1, 2022. Senseonics selected VP of Finance, Rick Sullivan, to succeed Tressler as CFO. In an effort to ensure an orderly change, Tressler will remain with the company […]
Personnel
Dexcom names Jake Leach chief operating officer
Dexcom (Nasdaq:DXCM) announced that it promoted chief technology officer Jake Leach to the chief operating officer (COO) role. Leach served as CTO since 2018, leading the company’s research, product development, product management and engineering departments. He joined the company in 2004 to lead the development of sensor electronics for its first commercial continuous glucose monitor […]
Hygieia appoints diabetes veteran Doug Lawrence as CEO
Hygieia — a developer of digital therapeutics for insulin therapy — announced today that it appointed Doug Lawrence as its CEO. Lawrence will take the corner office at Livonia, Michigan-based Hygieia with responsibilities for leading operations, development, and global growth of the company and its d-Nav insulin management program. The FDA-cleared d-Nav system autonomously adjusts […]
Acorda Therapeutics COO resigns
Acorda Therapeutics (Nasdaq:ACOR) announced today that Chief Operating Officer Lauren Sabella will resign next month. Pearl River, New York-based Acorda develops therapies designed to restore function and improve the lives of those with neurological disorders. The therapies are delivered via inhalation through the company’s Arcus pulmonary delivery system. Sabella’s resignation will be made effective Sept. […]
Lyra Therapeutics appoints new chief medical officer
Lyra Therapeutics (Nasdaq:LYRA) announced today that it appointed Dr. Richard Nieman as its new chief medical officer (CMO). Nieman’s appointment as CMO of Lyra, which develops the XTreo — a platform for enabling precise, sustained and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues — will be […]
Teva appoints former Vertex exec as new head of R&D, CMO
Teva Pharmaceuticals (NYSE:TEVA) announced today that it appointed Dr. Eric A. Hughes as VP of global R&D and chief medical officer. Hughes’ employment becomes effective Aug. 1, 2022, and he will be based out of Tel Aviv, Israel-based Teva’s U.S. headquarters in Parsippany, New Jersey. The company develops generic and specialty medicines, including inhalation solutions. […]
Inovio names new chief medical officer
Inovio (Nasdaq:INO) announced today that it appointed Dr. Michael Sumner as its new chief medical officer (CMO). Sumner will oversee Inovio’s clinical-stage pipeline of DNA medicines, global clinical development, clinical operations and biostatistics efforts, along with regulatory affairs, pharmacovigilance and medical affairs. He will also serve on the company’s executive leadership team and report to […]
Vivera adds two industry veterans to its technology advisory board
Vivera announced today that it added Robert Massoudi and Bryan Hughes to its technology advisory board. Massoudi and Hughes will support Newport Beach, California–based Vivera in its product and software development initiatives while forging strategic partnerships for Zicoh, the company’s electronic dose-controlled medication delivery system designed to improve prescription drug adherence, including medications with a […]
Tandem Diabetes Care adds two new members to its board
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed two new independent members to its board of directors. Myoung Cha and Joao Malagueira have been named to the San Diego-based automated insulin delivery technology developer’s board, effective yesterday. “We welcome Joao and Myoung to our board of directors at this exciting stage in Tandem’s evolution,” […]
Owen Mumford appoints new director of R&D
Owen Mumford announced today that it appointed Bal Johal as its director of research and development, effective next month. Johal will become the director of R&D for the Woodstock, United Kingdom-based developer of medical devices, including the Aidaptus auto-injector, on July 4, 2022. She has most recently served as VP of product development, quality, regulatory […]
